 |
 |
Advance Publication Full Text (PDF)
Phase II trial of irinotecan and thalidomide in adults with recurrent glioblastoma...
Puduvalli et al. Neuro Oncol.2008;
0:
15228517-2007-060v1
|
|
|
|
|
| To view this item, select one of the options below: |
|
|
|
 |
Sign In |
|
|
|
|
|
|
Purchase Short-Term Access |
|
 |
Pay per Article - You may access this article (from the computer you are currently using) for 2 days for US$15.00. |
|
|
Regain Access - You can regain access to a recent Pay per Article or Pay per Issue purchase if your access period has not yet expired. |
|
|
|
|
Sign Up |
|
|
Subscribe to the Journal - Subscribe to the print and/or online journal. |
|
|
|
|
